Table I.
Brain area | Postsynaptic cell | Transmissi on | Drug treatment required | Induction | Expression | Examples In the literature3 |
---|---|---|---|---|---|---|
VTA | DA neurons | excitatory | 1 injection of cocaine, and other addictive drugs, as well as acute stress | Activation of NMDAR on DA neurons and D1-like receptors, presumably on excitatory afferents | Increase of AMPAR/NMDAR and rectification: insertion of GluA2-lacking AMPARs and decrease of NMDAR function | (Ungless et al., 2001) (Saal et al., 2003) (Bellone and Lüscher, 2006) (Mameli et al., 2011) |
DA neurons | inhibitory | 1 injection of morphine, cocaine, nicotine and stress | Nitric oxyde | Decreased GABA release. | (Nugent et al., 2007) (Nugent et al., 2009) | |
DA neurons | excitatory | Only present in slices of mice that have received cocaine injection | mGluR1 | Removel of GluA2-lacking AMPARs | (Bellone & Lüscher, 2006) (Mameli et al., 2007) | |
DA neurons | inhibitory | 5 daily injections of cocaine | BDNF | Decrease of the number of GABAA receptors | (Liu et al., 2005) | |
NAc | MSN | excitatory | Weeks after several days of cocaine self-administration (incubation of craving) | GluA2 lacking AMPARs | (Conrad et al., 2008) | |
MSN | excitatory | 7 injections of cocaine, followed by one week of withdrawal & one challenge injection | Decrease of AMPAR/NM DAR ratio | NMDAR dependent LTD, silent synapses | (Thomas et al., 2001) | |
MSN | excitatory | 5 daily injections, followed by 10–14 days of withdrawal | Increase of AMPAR/NMDAR ratio | (Kourrich et al., 2007) | ||
MSN | excitatory | Several injections of cocaine inhibit mGluR5 LTD Also 24h after a single exposure to cocaine |
Post mGluR5 | Presynaptic via endocannabinoids | (Moussawi et al., 2009) | |
MSN (D2 expressing) | excitatory | Blocked 24h after oneinjection of cocaine | TrpV1 channel | Postsynaptic | (Grueter 2010) | |
Medial PFC | Pyramidal neurons | excitatory | 3 week withdrawal and then cue presentations | Cue induced decrease AMPAR/NMDAR | (Van den Oever et al., 2008) | |
Layer V pyramidal neurons | Inhibitory/excit atory | 7 daily injections, followed by 5–17 days of withdrawal | BDNF-dependent decrease of GABAA transmission | facilitated LTP | (Lu et al., 2010) |